Navigation Links
Leading reason for corneal transplants comes into focus

Guided by families with an unusual number of cases, scientists at Johns Hopkins have discovered the genetic origins of at least one form of Fuchs corneal dystrophy, FCD, the leading reason for corneal transplantation in the United States.

In one form or another, FCD's trademark deterioration of the cells covering the clear, outermost lens of the eye affects more than 4 percent of the population over 40. Late in life, the dystrophy causes swelling of the cornea and can severely affect vision, making it impossible to see well even with glasses or contact lenses. It's believed that various forms of FCD are due to multiple gene mutations.

In a report in the September issue of Investigative Ophthalmology, a team led by Hopkins ophthalmologist John Gottsch, M.D., says they were able to map a common form of Fuchs, found most often in women, to chromosome 18.

"Finding this chromosomal locus is putting us in the right neighborhood to find culprit genes," says Gottsch. "Now we have to start knocking on every door."

Gottsch is heartened by success with earlier Fuchs gene-hunting studies. The Hopkins group tracked down its first FCD-related gene in a Virginia family with multiple, early onset cases. That gene, labeled COL8A2, was mapped to chromosome 1.

Prior to that, a large Indiana family with FCD, including a boy of 10, led the team to yet another gene variant, on chromosome 13.

The scientists use linkage analysis, a process-of-elimination gene-hunting technique that analyzes inheritance patterns in families with relatively large numbers of affected individuals and trace genetic traits co-inherited or "linked" with the disorder. Researchers search for a common location for all the linked traits until they wind up with a single chromosome address.

In his latest study, Gottsch used not only linkage analysis but also a method of identifying variations in DNA sequences to examine three FCD families in which
'"/>

Source:Johns Hopkins Medical Institutions


Page: 1 2 3

Related biology news :

1. Leading scientists rank endangered dolphins, porpoises most in need of immediate action
2. Leading lampreys to slaughter: Pheromone for scourge of Great Lakes identified
3. Bobbing birds do it for a reason
4. The reason why antiviral therapy cant annihilate HIV infection, and what to do about it
5. A reason why video games are hard to give up
6. Pennsylvania researchers find liver transplants provide metabolic cure for rare genetic disease
7. Stem cell transplants improve recovery in animal models for stroke, cerebral palsy
8. Predicting successful outcomes in living-donor liver transplants
9. What animals can tell us about hemorrhage, organ transplants and aging
10. Protein may hold key to decreasing organ dysfunction rates in heart transplants
11. Stem cell transplants explored at Stanford as a possible treatment for hearing loss

Post Your Comments:
(Date:11/25/2009)...t State University assistant professors recently r...on (NSF) to continue research beneficial to unders...90,000. , Christopher Blackwood, assistant profe... awarded grants to support two separate research p... Litter Decomposer Communities and Functions from ...
(Date:11/24/2009)...usands of years it has been prescribed by traditio... from headaches and stomach pain to fever and flu....le University have been able to scientifically pro...a otherwise known as Brazilian mint. , Testing ... led by researcher Graciela Rocha was able to show...
(Date:11/24/2009)...science is opening new doors to understanding how ... hearing of a marine mammal or if they hear it at...X-ray scanners that NASA uses to detect flaws in t...now allowing scientists to peek inside the giant h...hree-dimensional replicas of a whale,s hearing ana...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Voler Systems Reports 50 25 Growth 14626 1Voler Systems Reports 50 25 Growth 14626 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 1Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 2Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 3Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 4
...mmonwealth University Massey Cancer Center have id...ible new therapeutic target to improve the efficac...In the Nov. 1 issue of the journal Cancer Research...er cells and established a role of sphingosine kin...id mediator sphingosine-1-phosphate in the death o...
...the world is still plagued by diseases we cannot t...ast complexity of the human immune system. Danish ... help expose a complicated but crucial part of the...an lead to entirely new vaccines and treatments. ... of Health Sciences at the University of Copenhage...
...can contribute as much as vehicles to carbon emiss...hly variable. New research published in the online... quantifies these emissions and suggests fires wil...forts. , Christine Wiedinmyer of the National Cen... University of Colorado, both in Boulder, US, used...
Other Biology News:Potential new therapeutic molecular target to fight cancer 2US faces burning emissions issue 2
(Date:11/25/2009)...ire-FirstCall/--ArdeaBiosciences,Inc.(Nasdaq: RDEA...tandchiefexecutiveofficer,willpresentatthePiperJaf...ondetailsareasfollows:,PiperJaffray21stAnnualHeal...2:00p.m.EasternTime,Location:TheNewYorkPalaceHotel...r.net/ireye/,target=,_blank,title=,http://www.cor...
(Date:11/24/2009)...ew York investment bank KTA Capital,s client Neure....7 mil convertible note private placement with a U...was arranged by KTA Capital as Neuren,s exclusive ... New York (PRWEB) November 23, 2009 -- The in...C ("KTA Capital") has announced that its...
(Date:11/24/2009)...ire-FirstCall/--Sigma-AldrichCorporation(Nasdaq: S...sday,December1stat1:45PMGMTinLondon,7:45AMUS/CST.I...theInternetavailableat http://inve s tor.sig m...ntoaccessthisfile. ,, AboutSigma-Aldrich: Si...ompany.Itschemicalandbiochemicalproductsandkitsare...
(Date:11/24/2009)...PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX...commercializingnovelpainmanagementtherapies,announ...iveOfficer,isscheduledtopresentatthe21stAnnualPipe...009atTheNewYorkPalaceHotelinNewYork,NewYork. ,,...er,willbeavailabletorespondtoquestionsduringthepre...
Breaking Biology Technology:Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
... SBIR Grant Funding to Advance the Development of ... RNAi Drugs, CARLSBAD, Calif., Oct. 3 Isis,Pharm...that it has been,awarded a multi-year Phase 2 Smal... National Institutes of Health (NIH) for up to $1.... exploit the RNA interference (RNAi),antisense mec...
...T LAFAYETTE, Ind. - Engineers have shown how to gr...es onto the surfaces of computer chips to enhance ...ps connect to cooling devices called heat sinks. ,...n to outperform conventional "thermal interface ma... does not require elaborate clean-room environment...
...A, Calif., Oct. 2 MannKind Corporation,(Nasdaq: ...a total of,27,014,686 shares of its common stock i...ts principal stockholder, Chief Executive Officer ... groups of investors,including accounts managed by...d shares, 15,940,489 shares were sold to Mr. Mann ...
Other Biology Technology:Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics 2Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics 3Nanotube forests grown on silicon chips for future computers, electronics 2Nanotube forests grown on silicon chips for future computers, electronics 3MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 2MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 3
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Glycogen Coprecipitant from Bioline
Biology Products: